Centene Corp CNC stock is rallying Thursday after the insurer confirmed its fiscal 2025 outlook of roughly $1.75 adjusted EPS—beating Wall Street's$1.69 consensus—despite having pulled prior guidance in July over preliminary actuarial data concerns.The company reported second-quarter sales surged 22% year-over-year to $48.74 billion, comfortably exceeding the consensus estimate of$44.48 billion. However, this revenue performance was overshadowed by substantial increases in medical costs.Also Read: Analyst ...